Van Berkom & Associates INC Decreased Stake in Chemed Corp New (CHE) by $9.68 Million; Shares Rose

June 27, 2018 - By Clyde Turner

During Q1 2018 the big money sentiment is 0.96. That’s change of 2017Q4’s as. 26 investors sold all, 90 reduced holdings as CHE ratio is the same. 70 grew holdings while only 41 funds amassed holdings. Funds hold 14.70 million shares thus 1.09% less from 2017Q4’s 14.86 million shares. Stratos Wealth Prtnrs stated it has 0% of its capital in Chemed Corporation (NYSE:CHE). Fmr Ltd Liability holds 658,484 shs. Guggenheim Capital Lc, a Illinois-based fund reported 7,670 shs. California Pub Employees Retirement accumulated 66,855 shs. Amer Interest Grp has 10,060 shs for 0.01% of their capital. Schroder Inv Mgmt Grp stated it has 3,994 shs. Voya Invest Mgmt Limited Liability Corp reported 0.16% stake. 5,090 are owned by Systematic Lp. Spark Investment Lc owns 1,800 shs for 0.03% of their capital. Federated Investors Inc Pa has 0% invested in Chemed Corporation (NYSE:CHE) for 10 shs. Canada Pension Plan Investment Board invested in 41,100 shs or 0.02% of the stock. Macquarie Group Limited owns 0% invested in Chemed Corporation (NYSE:CHE) for 172 shs. Fiera Cap Corporation invested in 39,292 shs or 0.05% of the stock. Etrade Mngmt Llc owns 2,579 shs. South Dakota Invest Council invested in 0.03% or 4,200 shs.

CHE registered $34.61 million net activity with 0 insider purchases and 17 insider sales since January 12, 2018. Dallob Naomi C had sold 1,050 shs worth $269,850 on Wednesday, February 21. MCNAMARA KEVIN J sold $6.59M worth of Chemed Corporation (NYSE:CHE) on Tuesday, April 24. On Wednesday, May 2 12,919 shs were sold by Westfall Nicholas Michael, worth $4.04 million. 10,000 shs valued at $3.16M were sold by WILLIAMS DAVID PATRICK on Monday, May 7. On Friday, June 22 GRACE PATRICK P also sold $80,940 worth of Chemed Corporation (NYSE:CHE). On Wednesday, April 25 Shares for $428,257 were sold by LEE SPENCER S.

The holdings In Chemed Corp New (CHE) was reduced held by Van Berkom & Associates Inc. According to 2018Q1 SEC form the reduction is 9.32%. The company’s stock rose 24.64% while stock markets declined as Van Berkom & Associates Inc sold 35,587 shares. At the end of 2018Q1, the institutional investor held 346,383 shares of the medical and nursing services company, valued at $94.51M, down from 381,970 at the end of the previous reported quarter. $5.12B is the MC of Chemed Corp New. CHE is touching $321.29 during the last trading session, after decreased 0.79%.Chemed Corporation has volume of 57,036 shares. Since June 27, 2017 CHE has risen 61.23% and is uptrending. CHE outperformed by 48.66% the S&P 500.

According to a filing the Van Berkom & Associates Inc’s stake in Euronet Worldwide Inc (NASDAQ:EEFT) was increased by 112,973 shares to 886,126 shares valued at $69.93M in 2018Q1. It operates about $3.36B and $3.30B US Long portfolio. Van Berkom & Associates Inc has risen its stake in Intl Fcstone Inc (NASDAQ:INTL) and also increased its holding in Iridium Communications Inc (NASDAQ:IRDM) by 740,323 shares in the quarter, for a total of 5.84 million shares.

Chemed Corporation (NYSE:CHE) is awaited to announce earnings on July, 24., according to RTT. EPS of $2.68 is 24.65 % up from 2017’s $2.15 EPS. This could be $42.72M profit for CHE assuming the current $2.68 EPS will become reality. -1.47 % negative EPS growth is what Wall Street’s predicts after $2.72 reported EPS previous quarter.

Another two news for Chemed Corporation (NYSE:CHE) were briefly posted by: on June 08, 2018 with title “S&P indexes swap firms due to shifting market caps; FSB to SmallCap 600”. The other‘s article was titled “VITAS HEALTHCARE TO ATTEND AHIP INSTITUTE & EXPO 2018” and posted on June 21, 2018.

Chemed Corporation (NYSE:CHE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: